+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gout Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Gout Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Gout Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 93 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 5593746
Description Jump to:
Gout therapeutics include NSAIDs, corticosteroids, colchicine, and urate-lowering therapies (ULTs) to manage hyperuricemia and acute gout attacks, affecting 0.5-1% of the global population, with higher rates (2-4%) in high-income countries. The market is driven by rising obesity (650 million people), metabolic syndrome, and dietary shifts, which increase hyperuricemia prevalence (5-10%).

Gout’s association with cardiovascular and kidney diseases, elevating heart event risk by 30%, underscores early treatment needs. Novel drugs like pegloticase address refractory cases, while increased diagnosis and health education boost demand. The global gout therapeutics market is estimated at USD 1.5-3.0 billion in 2025, with a CAGR of 5%-10% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high gout prevalence and advanced treatments, while Canada focuses on lifestyle interventions.
  • Europe: Germany, France, and the UK drive growth with robust rheumatology care.
  • Asia Pacific: China and India see rising demand due to dietary changes, with Japan emphasizing ULTs.
  • Rest of the World: Brazil expands access to generics, while the Middle East addresses metabolic syndrome.

Distribution Channel Analysis

  • Hospital Pharmacy: Expected growth of 5.5%-10.5%, driven by acute gout management. Trends focus on IV therapies.
  • Retail Pharmacy: Projected growth of 5.2%-10.2%, linked to chronic ULTs. Advances emphasize patient education.
  • Online Pharmacy: Anticipated growth of 5.0%-10.0%, covering digital access. Trends highlight subscription models.

Type Analysis

  • NSAIDs: Expected growth of 4.8%-9.8%, valued for acute relief. Trends focus on low-dose options.
  • Corticosteroids: Projected growth of 4.7%-9.7%, suited for severe flares. Advances emphasize short-term use.
  • Colchicine: Anticipated growth of 5.0%-10.0%, critical for acute attacks. Trends highlight generics.
  • Urate-Lowering Agents: Expected growth of 5.5%-10.5%, favored for chronic management. Trends focus on novel drugs.
  • Others: Expected growth of 4.5%-9.5%, covering biologics. Developments prioritize refractory cases.

Key Market Players

  • GSK: Offers colchicine for acute gout.
  • Takeda: Develops ULTs for chronic management.
  • Amgen: Focuses on biologics for refractory gout.
  • Novartis: Provides anti-inflammatory therapies.
  • Teva: Supplies affordable generics.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, due to regulatory barriers, but generics lower entry hurdles.
  • Threat of Substitutes: Low, as lifestyle changes are insufficient for severe gout, though diet competes.
  • Bargaining Power of Buyers: High, with generics increasing price competition.
  • Bargaining Power of Suppliers: Low, with multiple API providers.
  • Competitive Rivalry: High, with players competing on price and novel therapies.

Market Opportunities and Challenges

Opportunities:

  • Addressing gout, affecting 0.5-1% globally, with ULTs.
  • Managing metabolic syndrome, impacting 50% of gout patients.
  • Leveraging novel drugs like pegloticase for refractory cases.
  • Utilizing increased diagnosis rates, up to 50% in high-income countries.
  • Meeting demand driven by obesity and dietary shifts.
  • Supporting cardiovascular risk reduction in gout patients.

Challenges:

  • High costs of novel biologics.
  • Patient adherence issues with long-term ULTs.
  • Regulatory delays for new drugs.
  • Competition from generics reducing prices.
  • Limited awareness in low-income regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Gout Therapeutics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Gout Therapeutics Market in North America (2020-2030)
8.1 Gout Therapeutics Market Size
8.2 Gout Therapeutics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Gout Therapeutics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Gout Therapeutics Market in South America (2020-2030)
9.1 Gout Therapeutics Market Size
9.2 Gout Therapeutics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Gout Therapeutics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Gout Therapeutics Market in Asia & Pacific (2020-2030)
10.1 Gout Therapeutics Market Size
10.2 Gout Therapeutics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Gout Therapeutics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Gout Therapeutics Market in Europe (2020-2030)
11.1 Gout Therapeutics Market Size
11.2 Gout Therapeutics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Gout Therapeutics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Gout Therapeutics Market in MEA (2020-2030)
12.1 Gout Therapeutics Market Size
12.2 Gout Therapeutics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Gout Therapeutics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Gout Therapeutics Market (2020-2025)
13.1 Gout Therapeutics Market Size
13.2 Gout Therapeutics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Gout Therapeutics Market Size by Type
Chapter 14 Global Gout Therapeutics Market Forecast (2025-2030)
14.1 Gout Therapeutics Market Size Forecast
14.2 Gout Therapeutics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Gout Therapeutics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 GSK
15.1.1 Company Profile
15.1.2 Main Business and Gout Therapeutics Information
15.1.3 SWOT Analysis of GSK
15.1.4 GSK Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.2 Takeda
15.2.1 Company Profile
15.2.2 Main Business and Gout Therapeutics Information
15.2.3 SWOT Analysis of Takeda
15.2.4 Takeda Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.3 Amgen
15.3.1 Company Profile
15.3.2 Main Business and Gout Therapeutics Information
15.3.3 SWOT Analysis of Amgen
15.3.4 Amgen Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.4 Novartis
15.4.1 Company Profile
15.4.2 Main Business and Gout Therapeutics Information
15.4.3 SWOT Analysis of Novartis
15.4.4 Novartis Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.5 Regeneron
15.5.1 Company Profile
15.5.2 Main Business and Gout Therapeutics Information
15.5.3 SWOT Analysis of Regeneron
15.5.4 Regeneron Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.6 AstraZeneca
15.6.1 Company Profile
15.6.2 Main Business and Gout Therapeutics Information
15.6.3 SWOT Analysis of AstraZeneca
15.6.4 AstraZeneca Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.7 Merck
15.7.1 Company Profile
15.7.2 Main Business and Gout Therapeutics Information
15.7.3 SWOT Analysis of Merck
15.7.4 Merck Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.8 Zydus Group
15.8.1 Company Profile
15.8.2 Main Business and Gout Therapeutics Information
15.8.3 SWOT Analysis of Zydus Group
15.8.4 Zydus Group Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.9 Teva
15.9.1 Company Profile
15.9.2 Main Business and Gout Therapeutics Information
15.9.3 SWOT Analysis of Teva
15.9.4 Teva Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.10 Arrowhead Pharmaceuticals
15.10.1 Company Profile
15.10.2 Main Business and Gout Therapeutics Information
15.10.3 SWOT Analysis of Arrowhead Pharmaceuticals
15.10.4 Arrowhead Pharmaceuticals Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.11 Mylan
15.11.1 Company Profile
15.11.2 Main Business and Gout Therapeutics Information
15.11.3 SWOT Analysis of Mylan
15.11.4 Mylan Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.12 Teijin Pharma
15.12.1 Company Profile
15.12.2 Main Business and Gout Therapeutics Information
15.12.3 SWOT Analysis of Teijin Pharma
15.12.4 Teijin Pharma Gout Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Gout Therapeutics Report
Table Data Sources of Gout Therapeutics Report
Table Major Assumptions of Gout Therapeutics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Gout Therapeutics Picture
Table Gout Therapeutics Classification
Table Gout Therapeutics Applications
Table Drivers of Gout Therapeutics Market
Table Restraints of Gout Therapeutics Market
Table Opportunities of Gout Therapeutics Market
Table Threats of Gout Therapeutics Market
Table COVID-19 Impact For Gout Therapeutics Market
Table Raw Materials Suppliers
Table Different Production Methods of Gout Therapeutics
Table Cost Structure Analysis of Gout Therapeutics
Table Key End Users
Table Latest News of Gout Therapeutics Market
Table Merger and Acquisition
Table Planned/Future Project of Gout Therapeutics Market
Table Policy of Gout Therapeutics Market
Table 2020-2030 North America Gout Therapeutics Market Size
Figure 2020-2030 North America Gout Therapeutics Market Size and CAGR
Table 2020-2030 North America Gout Therapeutics Market Size by Application
Table 2020-2025 North America Gout Therapeutics Key Players Revenue
Table 2020-2025 North America Gout Therapeutics Key Players Market Share
Table 2020-2030 North America Gout Therapeutics Market Size by Type
Table 2020-2030 United States Gout Therapeutics Market Size
Table 2020-2030 Canada Gout Therapeutics Market Size
Table 2020-2030 Mexico Gout Therapeutics Market Size
Table 2020-2030 South America Gout Therapeutics Market Size
Figure 2020-2030 South America Gout Therapeutics Market Size and CAGR
Table 2020-2030 South America Gout Therapeutics Market Size by Application
Table 2020-2025 South America Gout Therapeutics Key Players Revenue
Table 2020-2025 South America Gout Therapeutics Key Players Market Share
Table 2020-2030 South America Gout Therapeutics Market Size by Type
Table 2020-2030 Brazil Gout Therapeutics Market Size
Table 2020-2030 Argentina Gout Therapeutics Market Size
Table 2020-2030 Chile Gout Therapeutics Market Size
Table 2020-2030 Peru Gout Therapeutics Market Size
Table 2020-2030 Asia & Pacific Gout Therapeutics Market Size
Figure 2020-2030 Asia & Pacific Gout Therapeutics Market Size and CAGR
Table 2020-2030 Asia & Pacific Gout Therapeutics Market Size by Application
Table 2020-2025 Asia & Pacific Gout Therapeutics Key Players Revenue
Table 2020-2025 Asia & Pacific Gout Therapeutics Key Players Market Share
Table 2020-2030 Asia & Pacific Gout Therapeutics Market Size by Type
Table 2020-2030 China Gout Therapeutics Market Size
Table 2020-2030 India Gout Therapeutics Market Size
Table 2020-2030 Japan Gout Therapeutics Market Size
Table 2020-2030 South Korea Gout Therapeutics Market Size
Table 2020-2030 Southeast Asia Gout Therapeutics Market Size
Table 2020-2030 Australia Gout Therapeutics Market Size
Table 2020-2030 Europe Gout Therapeutics Market Size
Figure 2020-2030 Europe Gout Therapeutics Market Size and CAGR
Table 2020-2030 Europe Gout Therapeutics Market Size by Application
Table 2020-2025 Europe Gout Therapeutics Key Players Revenue
Table 2020-2025 Europe Gout Therapeutics Key Players Market Share
Table 2020-2030 Europe Gout Therapeutics Market Size by Type
Table 2020-2030 Germany Gout Therapeutics Market Size
Table 2020-2030 France Gout Therapeutics Market Size
Table 2020-2030 United Kingdom Gout Therapeutics Market Size
Table 2020-2030 Italy Gout Therapeutics Market Size
Table 2020-2030 Spain Gout Therapeutics Market Size
Table 2020-2030 Belgium Gout Therapeutics Market Size
Table 2020-2030 Netherlands Gout Therapeutics Market Size
Table 2020-2030 Austria Gout Therapeutics Market Size
Table 2020-2030 Poland Gout Therapeutics Market Size
Table 2020-2030 Russia Gout Therapeutics Market Size
Table 2020-2030 MEA Gout Therapeutics Market Size
Figure 2020-2030 MEA Gout Therapeutics Market Size and CAGR
Table 2020-2030 MEA Gout Therapeutics Market Size by Application
Table 2020-2025 MEA Gout Therapeutics Key Players Revenue
Table 2020-2025 MEA Gout Therapeutics Key Players Market Share
Table 2020-2030 MEA Gout Therapeutics Market Size by Type
Table 2020-2030 Egypt Gout Therapeutics Market Size
Table 2020-2030 Israel Gout Therapeutics Market Size
Table 2020-2030 South Africa Gout Therapeutics Market Size
Table 2020-2030 Gulf Cooperation Council Countries Gout Therapeutics Market Size
Table 2020-2030 Turkey Gout Therapeutics Market Size
Table 2020-2025 Global Gout Therapeutics Market Size by Region
Table 2020-2025 Global Gout Therapeutics Market Size Share by Region
Table 2020-2025 Global Gout Therapeutics Market Size by Application
Table 2020-2025 Global Gout Therapeutics Market Share by Application
Table 2020-2025 Global Gout Therapeutics Key Vendors Revenue
Figure 2020-2025 Global Gout Therapeutics Market Size and Growth Rate
Table 2020-2025 Global Gout Therapeutics Key Vendors Market Share
Table 2020-2025 Global Gout Therapeutics Market Size by Type
Table 2020-2025 Global Gout Therapeutics Market Share by Type
Table 2025-2030 Global Gout Therapeutics Market Size by Region
Table 2025-2030 Global Gout Therapeutics Market Size Share by Region
Table 2025-2030 Global Gout Therapeutics Market Size by Application
Table 2025-2030 Global Gout Therapeutics Market Share by Application
Table 2025-2030 Global Gout Therapeutics Key Vendors Revenue
Figure 2025-2030 Global Gout Therapeutics Market Size and Growth Rate
Table 2025-2030 Global Gout Therapeutics Key Vendors Market Share
Table 2025-2030 Global Gout Therapeutics Market Size by Type
Table 2025-2030 Gout Therapeutics Global Market Share by Type

Companies Mentioned

  • GSK
  • Takeda
  • Amgen
  • Novartis
  • Regeneron
  • AstraZeneca
  • Merck
  • Zydus Group
  • Teva
  • Arrowhead Pharmaceuticals
  • Mylan
  • Teijin Pharma

Related Topics

Related Reports

Gout Therapeutics Market Report 2025 - Product Image

Gout Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drugs for the Treatment of Refractory Gout Market by Mechanism Of Action, Product Type, Route Of Administration, Distribution Channel, Dosage Form - Global Forecast to 2030 - Product Image

Drugs for the Treatment of Refractory Gout Market by Mechanism Of Action, Product Type, Route Of Administration, Distribution Channel, Dosage Form - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Gout Therapeutics Market by Drug Class, Distribution Channel, Route of Administration, Therapy Line - Global Forecast to 2030 - Product Image

Gout Therapeutics Market by Drug Class, Distribution Channel, Route of Administration, Therapy Line - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Gout Therapeutics - Global Strategic Business Report - Product Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Chronic Gout - Pipeline Insight, 2025 - Product Image

Chronic Gout - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.